Documents
The impact of the COVID-19 response on the supply chain, availability and cost of generic antiretroviral medicines for HIV in low- and middle-income countries
22 June 2020
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptions.
Related
U=U can help end HIV stigma and discrimination. Here’s how

27 February 2025
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them

18 February 2025
UNAIDS urges that all essential HIV services must continue while U.S. pauses its funding for foreign aid

01 February 2025